Skip to main content
Shree Pacetronix Ltd logo

Shree Pacetronix Ltd — Investor Relations & Filings

Ticker · 527005 ISIN · INE847D01010 LEI · 89450032UVOZNV46LX89 BSE.NS Manufacturing
Open in API
Filings indexed 8 across all filing types
Latest filing 2026-05-26 Report Publication Anno…
Country IN India
Listing BSE.NS 527005

About Shree Pacetronix Ltd

https://www.pacetronix.com

Shree Pacetronix Ltd specializes in the design, development, and manufacture of implantable cardiac pacemakers and associated medical equipment. The company's core product line features single-chamber and dual-chamber pacemakers, alongside pacing leads and external pulse generators. It focuses on delivering reliable cardiac rhythm management solutions through advanced electronic circuitry and biocompatible materials. The organization maintains manufacturing facilities compliant with international quality standards to ensure the safety and efficacy of its life-saving devices. Its operations encompass the full lifecycle of cardiac pacing technology, from research and development to global distribution, catering to healthcare providers requiring specialized cardiovascular intervention tools.

Recent filings

Filing Released Lang Actions
Kindly find enclosed herewith the extracts of Newspaper Publication Pursuant to Reg 47 of SEBI (LODR) Regulations, 2015 of the Audited Standalone & Consolidated Financial Results for the ....
Report Publication Announcement Classification · 88% confidence The document is a cover letter to the stock exchange listing department submitting press clippings of the audited standalone and consolidated financial results for Q4 and full year ended 31 March 2026. It states that the Board approved the results and that the extracts were published in newspapers today, pursuant to SEBI (LODR) Regulation 47. It does not contain the actual financial data, only an announcement that the report has been published, fitting the definition of a Report Publication Announcement (RPA).
2026-05-26 English
Pursuant to Regulation 30 read with Schedule III of the SEBI (LODR) Regulations, 2015, we would like to inform you that the Board of Directors, in their meeting held on 25th May, 2026, ....
Regulatory Filings Classification · 85% confidence The document is a formal disclosure under Regulation 30 of SEBI (LODR) Regs. It announces the board’s approval of new internal and statutory auditors and is filed to the stock exchange as a regulatory compliance notice. It does not contain financial data itself (not an annual or interim report), nor is it a management change per se, earnings release, or dividend notice. This is a general regulatory announcement under listing obligations, so it falls under Regulatory Filings (RNS).
2026-05-25 English
Pursuant to Regulation 30 read with Schedule III of the SEBI (LODR) Regulations, 2015, we would like to inform you that the Board of Directors, in their meeting held on 25th May, 2026, ....
Regulatory Filings Classification · 85% confidence The document is a SEBI LODR Regulation 30 disclosure letter notifying a stock exchange of board resolutions approving the appointment of an internal auditor and a new statutory auditor. It is an exchange filing under listing rules rather than a financial report, management presentation, or earnings release. It does not contain audit report details itself but simply announces auditor changes. Therefore it falls under General Regulatory Filings (RNS).
2026-05-25 English
Pursuant to Reg 30 read with Schedule III of the SEBI (LODR) Reg, 2015, we would like to inform you that the BOD, in their meeting held on 25.05.2026, have considered and approved the following ....
Regulatory Filings Classification · 75% confidence The document is a stock‐exchange filing under SEBI LODR Regulation 30 disclosing Board approvals for appointment of internal and statutory auditors. It is a listing disclosure, not a standalone audit report, not an AGM presentation, not an earnings release, and does not contain financial statements. It is a miscellaneous regulatory announcement, so it falls under the fallback category Regulatory Filings (RNS).
2026-05-25 English
Pursuant to Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the following: 1.Audited Financial Results ....
Audit Report / Information Classification · 88% confidence The document is a submission to the stock exchange under SEBI Regulations 33 and 30, providing the full audited standalone and consolidated financial results for Q4 and FY ended 31 March 2026 along with the Independent Auditor’s Report. It contains the audit opinion, audit basis, management’s and auditors’ responsibilities, and the full set of audited financial statements. This is not merely an earnings teaser or an announcement of availability; it is the audit report itself and the audited results, so it fits the definition of an Audit Report / Information (AR). FY 2026
2026-05-25 English
Pursuant to Reg 30 of SEBI (LODR) Reg, 2015, this is to inform you that in the meeting of the BOD of the Co held on Monday, 25.05.2026 at 3.00 P.M. at the RO of the Co, inter alia, transacted ....
Regulatory Filings Classification · 85% confidence The document is an official notice under SEBI Listing Regulations announcing the outcome of a Board meeting, including approval of audited financial results and auditor appointments. It does not contain actual financial data, nor is it the full report itself. It also does not announce changes to board members or senior management. It is a general regulatory disclosure under Regulation 30 and serves as a miscellaneous compliance filing. Therefore, it falls under Regulatory Filings (RNS).
2026-05-25 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.